Tecsys (TCS) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
22 Apr, 2026Executive summary
SaaS revenue grew 29% year-over-year to $67.1 million, with core product Elite up 32% and strong multi-site wins in healthcare and distribution; total revenue reached $176.5 million for FY25.
Net profit for Q4 2025 was $1.7 million (up 560% year-over-year), and full-year net profit was $4.5 million; adjusted EBITDA rose 55% in Q4 and 39% for the year to $13.4 million.
Professional services revenue hit a record CAD 16.2 million in Q4, with a record backlog of CAD 49 million, up 52% year-over-year.
Major SaaS deployment milestone with Roche at over 1,000 sites globally; expanded global footprint with new India subsidiary and Tecsys Innovation Lab.
Recognized by Gartner for the 14th consecutive time in the Challenger quadrant for WMS, with 40% of Gartner's healthcare supply chain top 25 using the platform.
Financial highlights
Q4 2025 total revenue was $46.6 million, up 6% year-over-year; SaaS revenue was $18.4 million, up 29% year-over-year.
Q4 gross margin was 51%, net profit was $1.7 million, and adjusted EBITDA was $4.3 million.
Fiscal 2025 SaaS revenue was $67.1 million, up 29%; total revenue was $176.5 million, up 3% (12% excluding hardware).
SaaS ARR reached $105.1 million, up 11% year-over-year; SaaS bookings were $6.5 million in Q4.
Ended FY25 with $27.6 million in cash and equivalents, no debt, and repurchased $6.9 million in shares.
Outlook and guidance
Fiscal 2026 SaaS revenue growth guidance is 20%-22%; total revenue growth guidance is 8%-10%.
Adjusted EBITDA margin guidance revised to 8%-9% due to increased R&D and marketing investments; adjusted EBITDA growth expected at 20%-30%.
Projected SaaS margin expansion, with consolidated SaaS margin expected to reach 75% by FY28.
Focused on expanding in healthcare and distribution, with robust pipeline and strong buyer intent across verticals.
Key themes for 2026: continued investment in product and marketing, AI-driven innovation, and customer satisfaction.
Latest events from Tecsys
- Directors and auditors elected, SaaS revenue and margins up, no shareholder questions.TCS
AGM 202422 Apr 2026 - Strong SaaS growth, margin gains, and strategic focus on high-win markets highlighted.TCS
AGM 202522 Apr 2026 - SaaS revenue rose 33%, bookings 57%, and guidance was reaffirmed amid strong governance actions.TCS
Q1 202522 Apr 2026 - Record SaaS growth, TecsysIQ launch, and cost-saving measures drive strong Q3 results.TCS
Q3 20265 Mar 2026 - Record SaaS growth and margin gains drive strong FY2024 results and positive outlook.TCS
Q4 20243 Feb 2026 - Q2 2025 SaaS revenue up 34% year-over-year, with ARR and RPO reaching record highs.TCS
Q2 202511 Jan 2026 - SaaS revenue and profit surged in Q2 FY26, with robust healthcare pipeline and record margins.TCS
Q2 20265 Dec 2025 - Record SaaS growth and margin expansion drive strong Q3 and positive FY25 outlook.TCS
Q3 20251 Dec 2025 - SaaS revenue rose 25%, ARR and EBITDA climbed, and guidance and dividend were maintained.TCS
Q1 202620 Oct 2025